Clinical and molecular markers in COPD
Chronic obstructive pulmonary disease (COPD) is a complex and heterogeneous disease, and there is a clinical need for validated markers and biomarkers that can contribute to the assessment of patients, risk prediction, treatment guidance, and assessment of response. Although according to the 2018 GO...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier España
2018-07-01
|
| Series: | Pulmonology |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2531043718300412 |